Psycho-oncology · 2026
Masculinity and Cancer Survivorship: A Systematic Review.
Систематический обзорСтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Wang Zixia, Shahrokni Ryan, Hoyt Michael A
Аннотация
BACKGROUND: Masculinity has been identified as a potential influence on psychological and physical health outcomes among male cancer survivors. This systematic review synthesized quantitative research examining associations between masculinity-related constructs and survivorship outcomes, including mental health, physical functioning, and health-related quality of life (HRQoL).
METHODS: A systematic search of PsycINFO, CINAHL, and PubMed was conducted through March 2025, following PRISMA guidelines. Studies were included if they quantitatively assessed masculinity-related variables in male cancer survivors and reported associations with HRQoL, mental health, or physical health outcomes. Study quality was assessed and a narrative synthesis was conducted.
RESULTS: Thirty-one studies met inclusion criteria. Traditional masculine norms (e.g., self-reliance, dominance, stoicism) and cancer-related masculine threat were consistently associated with poorer mental health, lower HRQoL, and greater symptom burden. In contrast, masculine self-esteem, a positive appraisal of one's masculinity post-cancer, was linked to better psychosocial outcomes and HRQoL across samples. Most studies were cross-sectional and focused on prostate cancer survivors, often lacking demographic diversity.
CONCLUSIONS: Masculinity-related constructs are meaningfully associated with cancer survivorship outcomes. Future work should prioritize longitudinal designs, cultural diversity, and clinical translation to develop gender-sensitive interventions targeting masculine identity disruption and promoting adaptive self-concepts.
METHODS: A systematic search of PsycINFO, CINAHL, and PubMed was conducted through March 2025, following PRISMA guidelines. Studies were included if they quantitatively assessed masculinity-related variables in male cancer survivors and reported associations with HRQoL, mental health, or physical health outcomes. Study quality was assessed and a narrative synthesis was conducted.
RESULTS: Thirty-one studies met inclusion criteria. Traditional masculine norms (e.g., self-reliance, dominance, stoicism) and cancer-related masculine threat were consistently associated with poorer mental health, lower HRQoL, and greater symptom burden. In contrast, masculine self-esteem, a positive appraisal of one's masculinity post-cancer, was linked to better psychosocial outcomes and HRQoL across samples. Most studies were cross-sectional and focused on prostate cancer survivors, often lacking demographic diversity.
CONCLUSIONS: Masculinity-related constructs are meaningfully associated with cancer survivorship outcomes. Future work should prioritize longitudinal designs, cultural diversity, and clinical translation to develop gender-sensitive interventions targeting masculine identity disruption and promoting adaptive self-concepts.